LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Radicicol | 10.0 | uM | LJP6 | 72 | hr | 1235 | 833 | 4513 | 0.1846 | -0.1229 |
MDA-MB-231 | Seliciclib | 10.0 | uM | LJP5 | 72 | hr | 1235 | 2463 | 4513 | 0.5458 | 0.3745 |
MDA-MB-231 | Ruxolitinib | 10.0 | uM | LJP5 | 72 | hr | 1235 | 2267 | 4513 | 0.5023 | 0.3146 |
MDA-MB-231 | XL147 | 10.0 | uM | LJP5 | 72 | hr | 1235 | 4168 | 4513 | 0.9235 | 0.8947 |
MDA-MB-231 | Saracatinib | 10.0 | uM | LJP6 | 72 | hr | 1235 | 2083 | 4513 | 0.4616 | 0.2585 |
MDA-MB-231 | Selumetinib | 10.0 | uM | LJP6 | 72 | hr | 1235 | 1577 | 4513 | 0.3495 | 0.1042 |
MDA-MB-231 | Sirolimus | 10.0 | uM | LJP6 | 72 | hr | 1235 | 3274 | 4513 | 0.7254 | 0.6219 |
MDA-MB-231 | Sorafenib | 10.0 | uM | LJP6 | 72 | hr | 1235 | 3819 | 4513 | 0.8463 | 0.7883 |
MDA-MB-231 | SU11274 | 10.0 | uM | LJP5 | 72 | hr | 1235 | 1156 | 4513 | 0.2561 | -0.0244 |
MDA-MB-231 | Fedratinib | 10.0 | uM | LJP5 | 72 | hr | 1235 | 398 | 4513 | 0.0882 | -0.2557 |
MDA-MB-231 | TGX221 | 10.0 | uM | LJP5 | 72 | hr | 1235 | 4077 | 4513 | 0.9033 | 0.8669 |
MDA-MB-231 | Torin1 | 10.0 | uM | LJP6 | 72 | hr | 1235 | 987 | 4513 | 0.2187 | -0.0759 |
MDA-MB-231 | Torin2 | 10.0 | uM | LJP5 | 72 | hr | 1235 | 534 | 4513 | 0.1184 | -0.2141 |
MDA-MB-231 | Tozasertib | 10.0 | uM | LJP5 | 72 | hr | 1235 | 1261 | 4513 | 0.2795 | 0.0078 |
MDA-MB-231 | Trametinib | 10.0 | uM | LJP5 | 72 | hr | 1235 | 1285 | 4513 | 0.2848 | 0.0152 |
MDA-MB-231 | TWS119 | 10.0 | uM | LJP5 | 72 | hr | 1235 | 1299 | 4513 | 0.2879 | 0.0194 |
MDA-MB-231 | Vemurafenib | 10.0 | uM | LJP5 | 72 | hr | 1235 | 2280 | 4513 | 0.5051 | 0.3185 |
MDA-MB-231 | Withaferin A | 10.0 | uM | LJP5 | 72 | hr | 1235 | 604 | 4513 | 0.1339 | -0.1927 |
MDA-MB-231 | Withaferin A | 10.0 | uM | LJP6 | 72 | hr | 1235 | 593 | 4513 | 0.1314 | -0.1962 |
MDA-MB-231 | WYE-125132 | 10.0 | uM | LJP6 | 72 | hr | 1235 | 1212 | 4513 | 0.2686 | -0.0072 |
MDA-MB-231 | WZ3105 | 10.0 | uM | LJP5 | 72 | hr | 1235 | 702 | 4513 | 0.1556 | -0.1628 |
MDA-MB-231 | XMD11-50 | 10.0 | uM | LJP6 | 72 | hr | 1235 | 1168 | 4513 | 0.2588 | -0.0207 |
MDA-MB-231 | Y39983 | 10.0 | uM | LJP6 | 72 | hr | 1235 | 403 | 4513 | 0.0893 | -0.2541 |
MDA-MB-231 | YM 201636 | 10.0 | uM | LJP5 | 72 | hr | 1235 | 986 | 4513 | 0.2186 | -0.0761 |
MDA-MB-231 | ZSTK474 | 10.0 | uM | LJP6 | 72 | hr | 1235 | 1901 | 4513 | 0.4213 | 0.2031 |